Follow the people · Insider
Sanam Pangali
Sanam Pangali files insider transactions with the SEC as a chief legal officer of Alumis (ALMS). We hold 2 disclosed purchases and sales filed since 17 May 2024, 2 of them in the last 90 days.
- Files forALMS
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure5 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 July 2025 — 3 August 2026Chief Legal Officer · Alumis (ALMS)9 Form 4 lines · source: SEC Form 4
- Filed 15 May 2024 — 23 May 2024CLO & Head of People · Acelyrin (SLRN)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,364 shares of AlumisSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- exercised options over 5,000 shares of AlumisSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- ▼ sold on the open market 5,000 shares of AlumisSEC Form 48 July 2026Common Stock · traded 6 July 2026 · filed 8 July 2026
- exercised options over 5,000 shares of Alumis (a derivative holding)SEC Form 48 July 2026Stock Option (Right to Buy) · traded 6 July 2026 · filed 8 July 2026
- was granted 186,200 shares of Alumis (a derivative holding)SEC Form 428 January 2026Stock Option (Right to Buy) · traded 26 January 2026 · filed 28 January 2026
- was granted 186,200 shares of Alumis (a derivative holding)SEC Form 428 January 2026Stock Option (Right to Buy) · traded 26 January 2026 · filed 28 January 2026
- was granted 40,000 shares of Alumis (a derivative holding)SEC Form 431 July 2025Stock Option (Right to Buy) · traded 29 July 2025 · filed 31 July 2025
- was granted 10,000 shares of AlumisSEC Form 431 July 2025Common Stock · traded 29 July 2025 · filed 31 July 2025
- was granted 100,000 shares of Alumis (a derivative holding)SEC Form 414 July 2025Stock Option (Right to Buy) · traded 10 July 2025 · filed 14 July 2025
- was granted 328,860 shares of Acelyrin (a derivative holding)SEC Form 424 May 2024Employee Stock Option (right to buy) · traded 23 May 2024 · filed 24 May 2024
- had shares withheld for tax on 921 shares of AcelyrinSEC Form 417 May 2024Common Stock · traded 15 May 2024 · filed 17 May 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.